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restriction fragment length polymorphism (RFLP). No sta-
tistically significant differences were found in the genotype 
or allele distributions of either rs920778 or rs12826786 
between glioma patients and controls, suggesting these 
SNPs are not associated with glioma risk. No significant 
associations were found between rs920778 variants and 
HOTAIR expression levels, while rs12826786 CT genotype 
was associated with increased intratumoral HOTAIR RNA 
levels when compared to TT genotype (p-value = 0.04). 
Univariate (Log-rank) and multivariate (Cox proportional) 
analyses showed both rs920778 CT and rs12826786 CT 
genotypes were significantly associated with longer overall 
survival of WHO grade III anaplastic oligodendroglioma 
patients. Our results suggest that HOTAIR SNPs rs920778 
and rs12826786 do not play a significant role in glioma 
susceptibility, but may be important prognostic factors in 
anaplastic oligodendroglioma patients. Future studies are 
warranted to validate and expand these findings, and to fur-
ther dissect the importance of these SNPs in glioma.
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Introduction
The recent advent of new sequencing technologies and 
genome-wide analysis has indicated that the vast majority 
of the genome is transcribed into non-coding transcripts, 
and that only 2% of the genome accounts for protein-cod-
ing transcripts, highlighting the importance of better under-
standing the functions of non-protein coding genes [1, 2]. 
Among non-coding RNAs, those longer than 200 nucleo-
tides—termed long non-coding RNAs (lncRNAs)—have 
emerged as highly attractive to cancer research due to their 
Abstract Abnormal expression of the long non-coding 
RNA HOX transcript antisense intergenic RNA (HOTAIR) 
is oncogenic in several human cancers, including glio-
mas. The HOTAIR single nucleotide polymorphisms 
(SNPs) rs920778 (C > T) and rs12826786 (C > T) present 
in the intronic enhancer and promoter regions of HOTAIR, 
respectively, are associated with expression, cancer suscep-
tibility, and patient prognosis in some tumor types. How-
ever, the relevance of these HOTAIR SNPs has not been 
studied in glioma. Here, we report a case-control study 
comprising 177 Portuguese glioma patients and 199 can-
cer-free controls. All subjects were genotyped by PCR and 
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ability to local or global regulation of gene expression via 
epigenetic, transcriptional or post-transcriptional mecha-
nisms [3]. Indeed, several lncRNAs were found to have cru-
cial roles in controlling cellular pathways and gene expres-
sion programs, thus impacting the oncogenic processes by 
presenting either oncogenic or tumor suppressive func-
tions [4]. The HOX Transcript Antisense Intergenic RNA 
(HOTAIR) is a trans-acting lncRNA able to reprogram 
chromatin organization throughout the genome, as it is 
scaffold for the binding of Polycomb Repressive Complex 
(PRC2) in its 5′ domain, while interacting on the 3′ domain 
with LSD1/REST/CoREST complex [5, 6]. The oncogenic 
roles of HOTAIR have been extensively described in several 
tumor types, and its abnormal expression was associated 
with patient poor prognosis, tumor growth, aggressiveness, 
progression, recurrence, metastatic dissemination, invasion, 
and chemoresistance (reviewed in [7, 8]).
Gliomas are the most frequent primary malignant 
tumors of the central nervous system in adults, and are 
divided in 2 main histological subtypes, including astro-
cytomas and oligodendrogliomas [9]. Astrocytomas rep-
resent the vast majority of all diagnosed gliomas (about 
70%), and are graded from I to IV according to the World 
Health Organization (WHO) [10]. Glioblastoma (GBM; 
astrocytoma WHO grade IV) is the most frequent and 
lethal, accounting for more than 50% of all glial tumor 
types [11], and is characterized by rapid growth and dif-
fuse invasiveness of the adjacent brain parenchyma [10]. 
While presenting different molecular profiles resulting 
from distinct etiological mechanisms, no environmental 
factors have been firmly associated with the develop-
ment of glioma, with exception of exposure to high-dose 
therapeutic radiation. Other putative causes may include 
familial aggregation, genetic syndromes, telomere main-
tenance and genetic polymorphisms [12–14]. The impor-
tance of inherited genetic variants in glioma risk has been 
highly addressed in both candidate-gene and genome-
wide association studies (GWAS) approaches, which 
revealed single nucleotide polymorphisms (SNPs) in can-
cer-related genes associated with glioma risk (e.g., TERT, 
EGF, EGFR, TGF-β1, CCDC26, CDKN2A/CDKN2B, 
PHLDB1 and RTEL1 [15–18]).
Although HOTAIR expression has been reported as 
crucial in the carcinogenic process of many cancer types, 
and its abnormal expression was associated with patient 
poor prognosis, tumor grade, growth and invasion, and as 
a putative therapeutic target in glioma [19–21], few stud-
ies have focused on the significance of SNPs in HOTAIR 
affecting cancer risk [22–28]. Critically, no studies have 
evaluated the impact of HOTAIR SNPs in glioma risk 
and patient prognosis. In this context, we evaluated 
how previously described HOTAIR SNPs rs920778 and 




This case-control study comprised 177 Portuguese gli-
oma patients from Hospital de Braga, Hospital de São 
João, and Hospital de Santo António, diagnosed between 
2004 and 2015, and 199 cancer-free individuals randomly 
selected from blood donors as controls. All participants 
were of Caucasian ethnic background. Tumors were clas-
sified according to WHO grading system [29], and clinico-
pathological data is summarized in Table 1. The study was 
conducted according to institutional and European Union 
ethical standards, and all subjects ensured written informed 
consent to participate in research studies.
Table 1  Clinicopathologic 
features of glioma patients and 
cancer-free controls
F female, M male, N/A not Applicable, SD standard deviation
Groups (WHO grade) Number
of cases
Age, y Gender
mean ± SD p-value M/F ratio p-value
Controls 199 46.4±14.0 N/A 1.88 N/A
Gliomas (II–IV) 177 57.7±12.4 p ≤ 0.001 1.68 p = 0.598
 Astrocytoma (II–IV) 137 58.3±12.1 p ≤ 0.001 1.85 p = 0.945
  Diffuse astrocytoma (II) 7 53.1±13.3 p = 0.153 1.33 p = 0.656
  Anaplastic astrocytoma (III) 5 56.0 ± 9.9 p = 0.080 0.25 p = 0.037
  Glioblastoma (IV) 118 59.0 ± 12.1 p ≤ 0.001 2.11 p = 0.654
  Gliosarcoma (IV) 7 53.7 ± 12.5 p = 0.131 1.33 p = 0.656
 Oligodendroglioma (II–III) 38 55.9 ± 13.5 p ≤ 0.001 1.24 p = 0.238
  Oligodendroglioma (II) 8 46.5 ± 14.3 p = 0.680 0.33 p = 0.020
  Anaplastic oligodendroglioma (III) 30 58.5 ± 12.3 p ≤ 0.001 1.73 p = 0.831




Genomic DNA was collected from peripheral blood leu-
kocytes by either proteinase K/chloroform/isopropanol 
treatment or  Citogene® DNA isolation kit (Citomed). 
HOTAIR SNPs rs920778 (C > T) and rs12826786 (C > T) 
were genotyped through PCR-based restriction fragment 
length polymorphism (RFLP). Fifty ng of DNA were used 
for PCR amplification with KAPA Taq DNA Polymerase 
(Kapa Biosystems). Primers sequences (following previ-
ous publications [22, 23]) and PCR conditions are listed 
in Supplementary Table  1. Ten μL of PCR product were 
enzymatically digested at 37 °C for 5 or 30 min with Fast-
Digest MspI (Thermo Scientific, rs920778) or FastDigest 
BglII (Thermo Scientific, rs12826786), respectively. Diges-
tion products were resolved in 4% agarose gel stained with 
GreenSafe Premium (Nzytech). For quality control, 20 
cases were confirmed by Sanger Sequencing, and the repro-
ducibility was 100%.
Intratumoral HOTAIR expression levels
Total RNA was collected from the available glioma tis-
sues from patients from Hospital de Braga using TRIzol 
method (Invitrogen), and cDNA was synthesized using 
High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems) according to the manufacturer’s protocol. 
Gene expression levels were assessed by quantitative real-
time PCR (qPCR; Kapa Biosystems) with the following set 
of primers: Sense- CAG TGG GGA ACT CTG ACT CG and 
Antisense- GTG CCT GGT GCT CTC TTA CC, and normal-
ized to the expression of HPRT1 (Sense- TGA GGA TTT 
GGA AAG GGT GT; Antisense- GAG CAC ACA GAG GGC 
TAC AA).
Statistical analysis
Statistical analyses were performed using SPSS 21.0 (IBM 
SPSS Statistics,  IBM®). The different allele and genotype 
frequencies in glioma patients and cancer-free controls 
were compared by Chi square test, and nonparametric Wil-
coxon-Mann Whitney test was used to compare age and sex 
distributions between these groups. Hardy–Weinberg equi-
librium was evaluated by Chi square test, comparing the 
expected and observed genotype frequencies of HOTAIR 
SNPs in control group. Linkage disequilibrium (LD) was 
calculated with the SHEsis program [30]. The intratumoral 
expression levels of HOTAIR were compared between 
genotypes using Mann–Whitney test. Odds ratio (OR) and 
95% confidence intervals (CI) for assessing differences 
in risk and survival were calculated by univariate and a 
Cox multivariate logistic regression (adjusted for patient 
age and sex). Effect sizes were measured using Cohen’s d 
values, and large effect sizes were considered for d ≥ 0.8 
[31]. No multiple comparisons corrections were performed. 
Patients’ overall survival was assessed by Kaplan–Meier 
survival curves, and the log-rank test was used to evaluate 




A total of 376 Portuguese subjects (177 glioma patients 
and 199 cancer-free control individuals) were genotyped 
to determine possible associations between HOTAIR 
rs920778 and rs12826786 polymorphisms and glioma risk 
or prognosis. The clinicopathological features of the con-
trols and cases are shown in Table 1. Statistical analysis of 
age (controls: 27–85 years; gliomas: 20–83 years) and sex 
distribution between control and all glioma cases showed 
significant differences for age (p-value ≤ 0.001), but not for 
sex (p-value = 0.598; Table 1).
Allelic frequencies and genotype distributions 
of HOTAIR SNPs
The genotype and allele frequencies of HOTAIR rs920778 
and rs12826786 polymorphisms in controls and glioma 
cases are shown in Table 2. The frequencies of TT, CT, and 
CC genotypes of rs920778 were 45.2, 42.2, and 12.6% in 
cancer-free controls, and 46.3, 40.1, and 13.6% in glioma 
patients, respectively. The allelic frequencies of T allele 
were 66.3% for controls and 66.4% for glioma. Regarding 
rs12826786 polymorphism, the frequencies of CC, CT, 
and TT genotypes were 47.2, 42.2, and 10.6% in controls, 
and 47.5, 43.5, and 9.0% in glioma cases, respectively, 
being the C allele the most representative in the control 
group (68.3%) and in glioma patients (69.2%). The dis-
tribution of rs920778 and rs12826786 allele frequencies 
in the control group was in Hardy–Weinberg equilibrium 
(p-value = 0.750 and p-value = 0.935, respectively). Inter-
estingly, these two polymorphisms were in strong linkage 
disequilibrium (D’ = 0.94 and  r2 = 0.79) in our datasets.
Association between HOTAIR SNPs and glioma risk
To define whether there was significantly increased glioma 
susceptibility due to the presence of particular HOTAIR 
rs920778 and rs12826786 genotypes, univariate (data not 
shown) and multivariate (Table 2) analyses were performed 
in all glioma and GBM patients, the most frequent subtype 
in our series (n = 118). No significant associations between 
these polymorphic variants and the risk for developing 
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glioma or GBM were found (p-value > 0.05). As expected, 
in the multivariate analyses, increased age was associated 
with increased risk for developing glioma (OR 1.063; 95% 
CI 1.045–1.081) or GBM (OR 1.071; 95% CI 1.050–1.092; 
Table 2).
Association between HOTAIR SNPs and gene 
expression levels in glioma specimens
The expression of HOTAIR was evaluated in 34 glioma 
tumor tissues (freshly collected adequately for RNA analy-
ses) to understand whether the rs920778 and rs12826786 
SNPs may be associated with HOTAIR mRNA levels 
(Fig.  1). For rs920778, there were no statistically signifi-
cant differences between CC, TT and CT genotypes and 
HOTAIR expression (Fig. 1a). In contrast, glioma subjects 
with the rs12826786 CT genotype had significantly higher 
tumor HOTAIR RNA levels than those with the TT geno-
type (Fig. 1b, p-value = 0.04).
Prognostic value of HOTAIR SNPs in glioma patients
We next investigated the association between these 
HOTAIR polymorphisms and patients’ overall survival in 
WHO grade IV GBM (n = 69) and WHO grade III ana-
plastic oligodendroglioma tumors (n = 18) with available 
follow-up data.
No statistically significant associations were found 
between rs920778 or rs12826786 polymorphisms and sur-
vival of GBM patients both by univariate (log rank test 
p-value = 0.458 and p-value = 0.306, respectively) and mul-
tivariate analyses adjusted for patients’ age and sex (Cox 
regression model p-values > 0.05; data not shown).
In contrast, univariate analyses for both SNPs in ana-
plastic oligodendroglioma patients showed that car-
riers of CT genotypes present longer overall survival 
than CC patients (p-value = 0.029 and p-value ≤ 0.001, 
for rs920778 and rs12826786, respectively; Fig.  2) or 
when compared to all other patients (CT vs CC + TT; 
Table 2  Multivariate logistic 
regression analysis of the 
association between rs920778 
and rs12826786 polymorphisms 
and glioma susceptibility by 
WHO grades
Boldfaced values indicate statistical significant differences at 5% level
a Odds ratio (OR) with 95% confidence intervals (CI), adjusted for age (as a continuous variable) and sex
Polymorphism Control Glioma (WHO 
grade II-IV)






  TT 90 82 – 54 –
  CT 84 71 0.969 (0.602–1.561) 45 0.927 (0.537–1.601)
  CC 25 24 1.060 (0.528–2.127) 14 0.867 (0.384–1.961)
  CC + CT 109 95 0.990 (0.635–1.545) 59 0.913 (0.547–1.522)
 Alleles
  T 264 235 – 153 –
  C 134 119 1.013 (0.727–1.412) 73 0.925 (0.630–1.359)
 Age 1.063 (1.045–1.081) 1.071 (1.050–1.092)
 Sex
  Male 130 111 – 76 –
  Female 69 66 1.005 (0.632–1.598) 37 0.716 (0.414–1.239)
rs12826786
 Genotypes
  CC 94 84 – 57 –
  CT 84 77 1.040 (0.651–1.661) 48 0.966 (0.565–1.654)
  TT 21 16 0.837 (0.384–1.825) 8 0.533 (0.202–1.411)
  TT + CT 105 93 0.998 (0.640–1.556) 56 0.872 (0.523–1.454)
 Alleles
  C 272 245 – 162 –
  T 126 109 0.959 (0.683–1.346) 64 0.821 (0.552–1.221)
 Age – – 1.063 (1.045–1.081) – 1.072 (1.051–1.093)
 Sex
  Male 130 111 – 76 –
  Female 69 66 1.000 (0.628–1.591) 37 0.701 (0.403–1.218)
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p-value = 0.043 and p-value ≤ 0.001, for rs920778 and 
rs12826786, respectively; data not shown). Addition-
ally for rs12826786, CT genotype patients also presented 
longer overall survival when compared to TT patients 
(p-value = 0.027; Fig. 2b).
Accordingly, Cox multivariate analysis showed that, 
for both SNPs, patients with the CT genotype present 
statistically significant longer overall survival than CC 
patients, independently of age and sex (p-value = 0.032 
and p-value = 0.010, for rs920778 and rs12826786, 
respectively; Table  3). Moreover, for rs12826786, the CT 
genotype also conferred longer overall survival than TT 
genotype patients (p-value = 0.032; Table 3) or when com-
pared to all other genotypes (p-value = 0.006; Table 3).
Discussion
The discovery of genetic factors associated with glioma 
susceptibility is required for a deeper understanding of 
this devastating disease, and to develop novel therapeutic 
approaches. HOTAIR is a known oncogenic lncRNA in 
several tumor types (reviewed in [7, 8]) including gliomas 
[15–17]. The roles of HOTAIR have been widely reported 
Fig. 1  HOTAIR expression levels in glioma tissues grouped by 
rs920778 and rs12826786 genotypes. Within rs920778 genotypes 
(a), HOTAIR expression levels are not statistically different (CC 
n = 5, TT n = 10, CT n = 19), whereas in rs12826786 polymorphism 
(b), patients presenting CT (n = 19) genotype have increased levels of 
HOTAIR in comparison to TT patients (n = 4), but not to CC patients 
(n = 11). The expression levels were normalized to HPRT1 expression 
using the 2−ΔCt method, transformed in logarithmic  (log10) scale, and 
are represented by mean ± SEM. *p-value = 0.04
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Fig. 2  Effect of HOTAIR rs920778 and rs12826786 polymorphisms 
in the survival of WHO grade III anaplastic oligodendroglioma 
patients. Kaplan–Meier survival curves indicate that a patients with 
CT genotype (n = 9) in rs920778 locus of HOTAIR present statisti-
cally significant longer overall survival than patients carrying the 
CC genotype (n = 3; Log-rank test, p-value = 0.029), but not the 
TT genotype (n = 6; Log-rank test, p-value = 0.124). No statisti-
cally significant associations were found between the TT and the 
CC genotypes (p-value = 0.541). b Patients harboring the CT geno-
type (n = 9) in rs12826786 SNP have statistically significant longer 
overall survival than patients with the CC genotype (n = 7; Log-rank 
test, p-value ≤ 0.001) and the TT genotype (n = 2; Log-rank test, 
p-value = 0.032). No statistically significant associations were found 




in cancer, but epidemiological studies evaluating tumor 
susceptibility conferred by genetic polymorphisms in its 
locus have not been extensively assessed [18–22]. Indeed, 
to the best of our knowledge, the current study is the first 
to evaluate associations between HOTAIR SNPs (rs920778 
and rs12826786) and glioma susceptibility and progno-
sis. We have analyzed a Portuguese population consisting 
of 177 glioma patients and 199 cancer-free controls. Our 
results showed that the allelic frequencies of HOTAIR SNPs 
rs920778 and rs12826786 were not significantly different 
between glioma patients and cancer-free controls. Impor-
tantly, for both polymorphisms, the genotypes frequencies 
in cancer-free controls are in agreement with those reported 
by the HapMap Project for subjects of European ancestry 
(HapMap-CEU, data not shown; http://hapmap.ncbi.nlm.
nih.gov/). Considering risk assessments, our results showed 
no significant associations between HOTAIR rs920778 
or rs12826786 and susceptibility for any WHO grade gli-
oma. Previous studies on the contribution of rs920778 to 
gastric cancer in a Turkish population [25] also showed 
no differences between patients and cancer-free controls; 
however, studies in other tumor types testing the impor-
tance of rs920778 or rs12826786 in the Chinese population 
have shown different allele frequencies between patients 
and cancer-free controls [22–24]. It was also showed previ-
ously that rs920778 variants do not influence gastric cancer 
susceptibility [25], whereas others have showed statisti-
cally significant associations between these SNPs and risk 
to develop gastric cardia adenocarcinoma [22], esopha-
geal squamous cell carcinoma (ESCC) [23], breast cancer 
[26–28] or gastric cancer [24]. Such discrepancies might be 
attributed to the different genetic backgrounds of the stud-
ied populations, different sample sizes, and/or to the variety 
of tumor types analyzed. Indeed, the expression patterns, 
the regulatory mechanisms, and the functions of lncRNAs 
are highly tissue-specific [32]. Because SNPs differentially 
influence the regulation of lncRNAs [33], in particular the 
SNPs in this study [22–24], it is possible that these SNPs 
may present distinct relevance in the context of different 
tumor types.
Since rs920778 and rs12826786 HOTAIR SNPs have 
been previously reported to be located in an intronic 
enhancer or in the promoter, respectively, we sought to 
understand if the different genotypes influence the expres-
sion levels of HOTAIR in glioma tissues. Our results 
showed that patients with the rs12826786 CT genotype 
presented increased intratumoral levels of HOTAIR, com-
pared to TT genotype but not CC, whereas in rs920778 no 
differences were found. Previous reports showed increased 
levels of HOTAIR in TT homozygous patients with gastric 
cancer or gastric cardia adenocarcinoma for rs920778 [24] 
or rs12826786 [22], respectively, again highlighting tumor 
type-specific roles of SNPs.
Given that HOTAIR expression is a known negative 
prognostic factor in glioma [19], we evaluated the impor-
tance of rs920778 or rs12826786 genotypes in the overall 
survival of the glioma patients from our dataset. We did not 
find any associations between rs920778 and rs12826786 
and overall survival for GBM patients (data not shown). 
Conversely, anaplastic oligodendroglioma patients present-
ing the CT genotype for rs920778 or rs12826786 had signif-
icantly longer overall survivals, both in univariate and age- 
and sex-adjusted multivariate analyses (Fig.  2; Table  3). 
Interestingly, in our GBM dataset, the TT genotype is the 
least frequent (n = 5/69), and these patients presented a ten-
dency for shorter overall survival in comparison to either 
CC or CT patients. Concordantly, a report in gastric car-
dia adenocarcinoma [22] has shown for the rs12826786 
SNP that TT genotype is the least frequent and that these 
patients also present a tendency to shorter overall survival 
in comparison to CT or CC, while presenting no overall 
survival differences for CC or CT patients. It is important 
to highlight that our survival analyses are based on a small 
Table 3  Multivariate Cox regression analysis of the association 
between rs920778 and rs12826786 polymorphisms and survival in 
WHO grade III anaplastic oligodendroglioma patients
Bold-faced values indicate statistical significant differences at 5% 
level
a Values that exceed Cohen’s d convention for a large effect size 
(d ≥ 0.8)
b Hazard ratio (HR) with 95% confidence intervals (CI), adjusted for 
age (as a continuous variable) and sex
Polymorphism Number 
of cases
p-value HR (95% CI)b Cohen’s d
rs920778
 Genotypes
  CT 9 0.094 – –
  CC 3 0.032 6.292 (1.175–33.69) 1.014a
  TT 6 0.267 2.320 (0.526–10.24) 0.464
  CC + TT 9 0.070 3.264 (0.909–11.72) 0.652
 Age 0.187 1.046 (0.978–1.119) 0.025
 Sex
  Male 13 – – –
  Female 5 0.236 2.305 (0.578–9.188) 0.460
rs12826786
 Genotypes
  CT 9 0.022 – –
  CC 7 0.010 12.34 (1.837–82.93) 1.386a
  TT 2 0.032 9.188 (1.209–69.81) 1.223a
  CC + TT 9 0.006 10.79 (1.998–58.24) 1.311a
 Age 0.392 1.026 (0.968–1.087) 0.014
 Sex
  Male 13 – – –
  Female 5 0.754 0.791 (0.182–3.437) −0.129
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cohort of patients (n = 18 for WHO grade III anaplastic oli-
godendroglioma and n = 69 for WHO grade IV GBM), for 
which we had available follow-up information. Nonethe-
less, our findings that rs920778 and rs12826786 CT geno-
types are associated with longer survival of WHO grade III 
anaplastic oligodendroglioma patients are integrally sup-
ported by complementary statistical approaches, including 
Log-rank tests (which take into consideration sample size), 
multivariate Cox regression models adjusted for potential 
confounding effects (like patient age and sex), as well as 
calculations of Hazard Ratios and Cohen’s d values (which 
relate to the effect size, and are independent of sample size; 
Fig.  2; Table  3). These findings suggest putative roles of 
these HOTAIR SNPs in the survival of anaplastic oligoden-
droglioma patients, warranting further validation by inde-
pendent studies with larger datasets.
In conclusion, our findings add to the body of knowl-
edge surrounding genetic polymorphisms as putative 
players affecting glioma risk or prognosis. We found that 
HOTAIR rs920778 and rs12826786 do not seem to play any 
major role in genetic susceptibility of glioma in the Por-
tuguese population. In contrast, HOTAIR rs12826786 pre-
sents genotype specific effect on tumoral HOTAIR expres-
sion levels, and both SNPs showed prognostic significance 
in the Portuguese anaplastic oligodendroglioma population. 
Therefore, HOTAIR rs920778 and rs12826786 may be use-
ful biomarkers to predict the outcome of WHO grade III 
anaplastic oligodendroglioma patients. Of note, these two 
SNPs were in strong linkage disequilibrium in the glioma 
population, which could partly explain the similar results 
obtained for both SNPs relating to risk and prognostic anal-
ysis. Further studies are required to validate and expand our 
results to populations with different genetic backgrounds 
to better understand the broader importance of these SNPs 
in gliomas. Taking advantage of genotyping projects (e.g., 
HapMap and the 1000genomes.org), it may be interesting 
to identify and study additional HOTAIR polymorphisms, 
which may have functional consequences and play a role in 
glioma pathophysiology.
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